Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Hidradenitis suppurativa improves with antiandrogen therapy.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone may influence COVID-19 severity and outcomes.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Anabolic steroid users may face higher risk of severe COVID-19.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Clascoterone 1% cream is a promising new treatment for acne.

Finasteride treatment changes Cx43 in rat testes, possibly causing fertility issues.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Clascoterone cream is a safer, effective acne treatment with fewer side effects.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

PCOS treatment should be personalized based on individual symptoms and health goals.

Oral contraceptives can effectively treat acne by reducing oil production.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.